Prescription data miners seek VT injunction

A trio of companies engaged in the business of selling prescribing information to drugmakers--a practice referred to as "data mining" are asking an appeals court to stop an anti-data-mining law from being enforced. The data, which is physician-specific, has been a very lucrative commodity, so in states where anti-data-mining laws have sprung up vendors have fought back vigorously.

IMS Health, SDI Health and Wolters Kluwer Health had lost a skirmish in April, when a federal judge said the Vermont legislature was within its rights. But the three aren't giving up, and are asking a circuit court to stop the law from going into effect next month.

This is just one battle in a drawn-out war waged by data-mining interests against state restrictions, which have sprung up in states like Vermont, New Hampshire and Maine. It's been years since Vermont legislature enacted a law banning the practice of collecting and analyzing prescribing data, then reselling it to pharmaceutical companies.

To learn more about the dispute:
- read this Modern Healthcare piece (reg. req.)

Related Articles:
Federal appeals court upholds NH data mining ban
DC considers pharma rep licenses, data mining limits
VT wins battle to bar marketing use of Rx data

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.